论文信息 - 618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR) - 字舞流文

618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR)

M. Kudo | A. Vogel | V. Breder | S. Qin | L. Fartoux | T. Yamashita | J. Yoon | G. Meier | C. Dutcus | C. Lopez | S. Hudgens | M. Sung | T. Tamai | K. Simon | N. Grunow | S. Kraljevic